Example: FDA refusal → investors
How Pro is designed to link FDA Complete Response Letters to what each company filed with the SEC and did next.
The question#
When FDA refused a drug, what did the company tell investors?
The answer#
| Company | Drug | Complete Response Letters | Where it stands |
|---|---|---|---|
| Aldeyra · ALDX | reproxalap | Apr 2, 2025 · Mar 16, 2026 | Resubmitted; CRL again |
| Outlook · OTLK | bevacizumab-vikg | Aug 27, 2025 · Dec 30, 2025 | Formal dispute resolution |
| Corcept · CORT | relacorilant | Jan 28, 2026 | Response in progress; securities litigation pending |
Where to check it today#
Open each company's page on the SEC Ephemeris (see the URL directory) for its letters, 8-K filings and 10-K, and what is in the graph. For the same question answered in full, with every quote checked, see the deep research question webs and the Ask the Ephemeris concept preview.